Hinova Pharmaceuticals Inc. A (688302) — Defensive Interval Ratio
Hinova Pharmaceuticals Inc. A (688302) has a Defensive Interval Ratio of 610 days as of June 2025. Defensive assets of CN¥224.64 Million (cash CN¥-, short-term investments CN¥220.52 Million, receivables CN¥4.13 Million) cover 610 days of daily cash needs of CN¥367.99K/day. Check how tangible is Hinova Pharmaceuticals Inc. A's equity to evaluate the tangible quality of the company's equity base.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
Hinova Pharmaceuticals Inc. A Defensive Interval Ratio (2019–2024)
This chart shows how Hinova Pharmaceuticals Inc. A's Defensive Interval Ratio has evolved across 4 annual periods from 2019 to 2024. As of June 2025, the ratio stands at 610 days, meaning defensive assets of CN¥224.64 Million can fund 610 days of operations without new revenue. Also explore 688302 net asset momentum to track the company's year-over-year net asset growth rate.
Annual Defensive Interval Ratio for Hinova Pharmaceuticals Inc. A (2019–2024)
The table below presents the year-by-year Defensive Interval Ratio for Hinova Pharmaceuticals Inc. A from 2019 to 2024, covering 4 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For live market cap and the full company financial profile, see Hinova Pharmaceuticals Inc. A market capitalisation.
| Year | DIR (days) | Defensive Assets (CNY) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 523 days | CN¥210.49 Million | CN¥402.61K/day | CN¥- | CN¥210.49 Million | ▼ -470 days |
| 2023 | 993 days | CN¥290.62 Million | CN¥292.73K/day | CN¥- | CN¥290.62 Million | ▲ +26 days |
| 2022 | 967 days | CN¥366.24 Million | CN¥378.83K/day | CN¥- | CN¥366.24 Million | ▲ +951 days |
| 2019 | 16 days | CN¥3.50 Million | CN¥220.55K/day | CN¥- | CN¥3.50 Million | — |